Russian Scientists Develop Stem Cell-Based Drug to Treat Brain Damage after Strokes

Russian researchers announced a significant breakthrough in the treatment of acute brain injuries, including strokes, Emirates News Agency (WAM), a partner of TV BRICS reported. 

A new drug uses stem cell-derived secretions to stimulate brain recovery and reduce neurological damage. 

According to experts, the therapy will target all types of strokes, in addition, it showed good results in preclinical trials. 

The treatment works by reducing cerebral haemorrhage and protecting affected neural tissues in the early stages following a stroke, making it a potential first-line intervention during the critical phase of patient care.

The newly developed drug leverages the therapeutic potential of mesenchymal stromal cells to tackle multiple aspects of brain injury in one approach.

The research team highlighted that the cell secretions promote neuroprotection, modulate inflammation, and enhance repair mechanisms within the damaged brain regions. These findings suggest a pathway for developing comprehensive treatments that could significantly improve outcomes for stroke patients worldwide.

Previously, Sada El- Balad and TV BRICS international media network signed an agreement on joint activities to strengthen Egypt's position in the international media space and to widely inform the population of the country and the Middle East about the development of BRICS' nations.